Literature DB >> 22488725

Methylmalonate impairs mitochondrial respiration supported by NADH-linked substrates: involvement of mitochondrial glutamate metabolism.

Daniela R Melo1, Sandra R Mirandola, Nilson A Assunção, Roger F Castilho.   

Abstract

The neurodegeneration that occurs in methylmalonic acidemia is proposed to be associated with impairment of mitochondrial oxidative metabolism resulting from methylmalonate (MMA) accumulation. The present study evaluated the effects of MMA on oxygen consumption by isolated rat brain mitochondria in the presence of NADH-linked substrates (α-ketoglutarate, citrate, isocitrate, glutamate, malate, and pyruvate). Respiration supported either by glutamate or glutamate plus malate was significantly inhibited by MMA (1-10 mM), whereas no inhibition was observed when a cocktail of NADH-linked substrates was used. Measurements of glutamate transport revealed that the inhibitory effect of MMA on respiration maintained by this substrate is not due to inhibition of its mitochondrial uptake. In light of this result, the effect of MMA on the activity of relevant enzymes involved in mitochondrial glutamate metabolism was investigated. MMA had minor inhibitory effects on glutamate dehydrogenase and aspartate aminotransferase, whereas α-ketoglutarate dehydrogenase was significantly inhibited by this metabolite (K(i) = 3.65 mM). Moreover, measurements of α-ketoglutarate transport and mitochondrial MMA accumulation indicated that MMA/α-ketoglutarate exchange depletes mitochondria from this substrate, which may further contribute to the inhibition of glutamate-sustained respiration. To study the effect of chronic in vivo MMA treatment on mitochondrial function, young rats were intraperitoneally injected with MMA. No significant difference was observed in respiration between isolated brain mitochondria from control and MMA-treated rats, indicating that in vivo MMA treatment did not lead to permanent mitochondrial respiratory defects. Taken together, these findings indicate that the inhibitory effect of MMA on mitochondrial oxidative metabolism can be ascribed to concurrent inhibition of specific enzymes and lower availability of respiratory substrates.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488725     DOI: 10.1002/jnr.23020

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  11 in total

1.  Ilex paraguariensis Attenuates Changes in Mortality, Behavioral and Biochemical Parameters Associated to Methyl Malonate or Malonate Exposure in Drosophila melanogaster.

Authors:  José Luiz Portela; Matheus Chimelo Bianchini; Aline Augusti Boligon; Murilo Ricardo Sigal Carriço; Rafael Roehrs; Félix Alexandre Antunes Soares; Marcelo Gomes de Gomes; Waseem Hassan; Robson Luiz Puntel
Journal:  Neurochem Res       Date:  2019-08-17       Impact factor: 3.996

2.  α-Ketoadipic Acid and α-Aminoadipic Acid Cause Disturbance of Glutamatergic Neurotransmission and Induction of Oxidative Stress In Vitro in Brain of Adolescent Rats.

Authors:  Janaína Camacho da Silva; Alexandre Umpierrez Amaral; Cristiane Cecatto; Alessandro Wajner; Kálita Dos Santos Godoy; Rafael Teixeira Ribeiro; Aline de Mello Gonçalves; Ângela Zanatta; Mateus Struecker da Rosa; Samanta Oliveira Loureiro; Carmen Regla Vargas; Guilhian Leipnitz; Diogo Onofre Gomes de Souza; Moacir Wajner
Journal:  Neurotox Res       Date:  2017-04-20       Impact factor: 3.911

3.  Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria.

Authors:  Parith Wongkittichote; Gary Cunningham; Marshall L Summar; Elena Pumbo; Patrick Forny; Matthias R Baumgartner; Kimberly A Chapman
Journal:  Mol Genet Metab       Date:  2019-10-17       Impact factor: 4.797

4.  Methylmalonic Acid Impairs Cell Respiration and Glutamate Uptake in C6 Rat Glioma Cells: Implications for Methylmalonic Acidemia.

Authors:  Renata T Costa; Marcella B Santos; Carlos Alberto-Silva; Daniel C Carrettiero; César A J Ribeiro
Journal:  Cell Mol Neurobiol       Date:  2022-06-08       Impact factor: 5.046

5.  Methylmalonic acid induces inflammatory response and redox homeostasis disruption in C6 astroglial cells: potential glioprotective roles of melatonin and resveratrol.

Authors:  Rômulo Rodrigo de Souza Almeida; Larissa Daniele Bobermin; Belisa Parmeggiani; Krista Minéia Wartchow; Diogo Onofre Souza; Carlos-Alberto Gonçalves; Moacir Wajner; Guilhian Leipnitz; André Quincozes-Santos
Journal:  Amino Acids       Date:  2022-08-04       Impact factor: 3.789

6.  Vitamin B(12) intake and status in early pregnancy among urban South Indian women.

Authors:  Tinu Mary Samuel; Christopher Duggan; Tinku Thomas; Ronald Bosch; Ramya Rajendran; Suvi M Virtanen; Krishnamachari Srinivasan; Anura V Kurpad
Journal:  Ann Nutr Metab       Date:  2013-01-22       Impact factor: 3.374

Review 7.  Methylmalonic and propionic acidemias: clinical management update.

Authors:  Jamie L Fraser; Charles P Venditti
Journal:  Curr Opin Pediatr       Date:  2016-12       Impact factor: 2.856

8.  Brain damage in methylmalonic aciduria: 2-methylcitrate induces cerebral ammonium accumulation and apoptosis in 3D organotypic brain cell cultures.

Authors:  Paris Jafari; Olivier Braissant; Petra Zavadakova; Hugues Henry; Luisa Bonafé; Diana Ballhausen
Journal:  Orphanet J Rare Dis       Date:  2013-01-08       Impact factor: 4.123

9.  Macrophages sensing oxidized DAMPs reprogram their metabolism to support redox homeostasis and inflammation through a TLR2-Syk-ceramide dependent mechanism.

Authors:  Vlad Serbulea; Clint M Upchurch; Katelyn W Ahern; Gael Bories; Paxton Voigt; Dory E DeWeese; Akshaya K Meher; Thurl E Harris; Norbert Leitinger
Journal:  Mol Metab       Date:  2017-11-07       Impact factor: 7.422

10.  TAT-MTS-MCM fusion proteins reduce MMA levels and improve mitochondrial activity and liver function in MCM-deficient cells.

Authors:  Tal Erlich-Hadad; Rita Hadad; Anat Feldman; Hagar Greif; Michal Lictenstein; Haya Lorberboum-Galski
Journal:  J Cell Mol Med       Date:  2017-12-19       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.